Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the long-term safety of lapaquistat acetate, once
daily (QD), as monotherapy or in combination with other lipid-lowering agents in Subjects
with Hypercholesterolemia.